IOVA
Iovance Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
时间:2024-12-21 06:00:00 市场: 美股
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.d., Ph.d. to Chief Regulatory Officer
时间:2024-11-27 05:01:00 市场: 美股 综合